Genome-wide association studies in AD have identified the variants of phosphatidylinositol-binding clathrin assembly protein (PICALM), which are associated with NFTs and co-localized with conformational abnormalities and hyperphosphorylated Tau proteins in late-onset AD (Ando et al., 2013). Here, PICALM is linked to Alzheimer disease.